RxDoctor Payments Data

Sarosh Bukhari, DO

Gastroenterology · Park Ridge, ILNPI 1306092648

Payments from drug & device makers

$83,377in general payments, 2019–2025

Across 728 payments — averaging $114.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$29K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$14K
  • AbbVie$13K
  • Phathom Pharmaceuticals, Inc.$12K
  • Bristol Myers Squibb$3K
  • Ironwood Pharmaceuticals, Inc$3K
  • plus $9K from 37 others

What the payments were for

  • Consulting fees$1,8002%
  • Speaking & faculty fees$64,32677%
  • Travel & lodging$1,9382%
  • Food & beverage$15,01418%
  • Education$2070%
  • Gifts$920%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$83,377 in reported general payments places this provider in the 90th percentile of 787 gastroenterology providers in Illinois.

See all gastroenterology providers in Illinois

Medicare billing

Part B allowed, 2024
$177,112
Medicare patients
759
Services billed
1,330

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab13$87,829
LinzessLinaclotide54$64,484
ZenpepLipase/Protease/Amylase18$45,242
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates149$8,698
Pantoprazole Sodium399$6,393
PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C37$5,187
Sucralfate39$4,614
Dexlansoprazole DrDexlansoprazole12$3,468
Omeprazole282$3,437
Balsalazide Disodium21$3,261
Famotidine231$2,684
SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag17$2,037
CholestyramineCholestyramine (With Sugar)24$2,022
Rabeprazole Sodium47$1,779
Dicyclomine Hcl91$1,704

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$13,484$64,48454 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCPlenvu$14,407$5,18737 claims
Braintree Laboratories, Inc.Suflave$333$2,03717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 787 gastroenterology providers in Illinois.

Other gastroenterology in Park Ridge

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →